Hadlima approved as fourth adalimumab biosimilar in U.S.July 23, 2019Psoriatic ArthritisPsoriasisPediatrics
Secukinumab reduced joint pain of psoriatic arthritis in early data from phase 3b trialJuly 16, 2019Psoriatic Arthritis
Unacceptable pain despite inflammation control commonly occurs in PsA patientsJuly 2, 2019Psoriatic Arthritis
Systemic psoriasis treatments less often prescribed in elderly with psoriasis, despite comparable response ratesJune 27, 2019PsoriasisPsoriatic Arthritis
Obesity might be targetable driver of psoriatic arthritis progressionJune 26, 2019Psoriatic Arthritis
Carotid ultrasound may aid cardiovascular risk stratification of patients with psoriatic diseaseJune 5, 2019Psoriatic ArthritisPsoriasis
Th17-associated cytokines, CRP fail as biomarkers for ustekinumab success in PsAMay 17, 2019Psoriatic Arthritis
Etanercept biosimilar SB4 a cost-effective alternative for psoriasis, PsAMay 14, 2019PsoriasisPsoriatic Arthritis
